-- Phase 2/3 GRANITE-CRC-1L trial has registrational intent -- -- Updated data from Phase 1/2 trial in end-stage metastatic MSS-CRC…
NEW YORK, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences (Nasdaq: TLSA) (“Tiziana”), a biotechnology company enabling breakthrough immunotherapies…
Transaction includes cash payments of $25 million and potential milestones of up to $450 million Sale aligns with VYNE’s strategic…
CARLSBAD, Calif., Jan. 13, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on…
MELBOURNE, Australia, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on…
San Clemente, CA, Jan. 13, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- On January 13, 2022, Global Wholehealth Partners Corporation…
Clinical trial to be conducted at the National University Cancer Institute, Singapore and the National Cancer Centre Singapore, in Collaboration…
Vancouver, British Columbia--(Newsfile Corp. - January 13, 2022) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"),…
Jackson Center, Pennsylvania--(Newsfile Corp. - January 13, 2022) - Halberd, Corp. (OTC PINK: HALB) ("HALB" or the "Company"), an innovative…
Award-winning organizations partner to advance medication safety, clinical outcomes, and operational efficiency BOSTON--(BUSINESS WIRE)--#Ivenix--Ivenix, Inc., a medical technology company with…